eNauka - pregled

Pregled prema Autor Cohen, Stanley B

Prikaz rezultata 1 do 9 od 9
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2019Efficacy and Safety of Fenebrutinib, a BTK Inhibitor, Compared to Placebo in Rheumatoid Arthritis Patients with Active Disease Despite TNF Inhibitor Treatment: Randomized, Double Blind, Phase 2 StudyCohen, Stanley B; Tuckwell, Katie; Kunder, Rebecca; Katsumoto, Tamiko R; Zhao, Rui; Berman, Alberto; Damjanov, Nemanja S; Fedkov, Dmytro; Jeka, Slawomir; Genovese, Mark CKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2009Evaluation of the Efficacy and Safety of Pamapimod, a p38 MAP Kinase Inhibitor, in a Double-Blind, Methotrexate-Controlled Study of Patients With Active Rheumatoid ArthritisCohen, Stanley B; Cheng, Tien-Tsai; Chindalore, Vishala; Damjanov, Nemanja S; Burgos-Vargas, Ruben; DeLora, Patricia; Zimany, Kathleen; Travers, Helen; Caulfield, John PNaučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2019Fenebrutinib Compared to Placebo and Adalimumab in Patients with Inadequate Response to Either Methotrexate Therapy Or Prior Tnf Therapy: Phase 2 StudyCohen, Stanley B; Tuckwell, Katie; Katsumoto, Tamiko R; Zhao, Rui; Lee, Chin; Berman, Alberto; Damjanov, Nemanja S; Fedkov, Dmytro; Jeka, Slawomir; Genovese, Mark CKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2020Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, PhaseIITrialCohen, Stanley B; ...; Damjanov, Nemanja S; ...; (broj, koautora 18)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2023Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 260 Weeks from the Select-Monotherapy StudySmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Ignacio, Vargas Juan; Damjanov, Nemanja S; Jain, Manish; Kato, K; Carter, K; Khan, N;
Camp, Heidi S; Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2020Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 WeeksSmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Vargas, Juan; Damjanov, Nemanja S; Jain, Manish; Song, Yanna; Khan, Nasser; Enejosa, Jeffrey;
Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2020Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks from the Select-Monotherapy StudySmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Vargas, Ignacio J; Damjanov, Nemanja S; Jain, Manish; Song, Yanna; Khan, Nasser; Enejosa, Jeffrey;
Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2019Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 WeeksSmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Ignacio, Vargas Juan; Damjanov, Nemanja S; Jain, Manish; Sui, Yunxia; Enejosa, Jeffrey; Pangan, Aileen L;
Camp, Heidi S; Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2019Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks from the Select-Monotherapy StudySmolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Ignacio, Vargas Juan; Damjanov, Nemanja S; Jain, Manish; Sui, Yunxia; Enejosa, Jeffrey; Pangan, Aileen L;
Camp, Heidi S; Cohen, Stanley B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.